BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 12015552)

  • 1. Boston: a magnetic hub.
    Smaglik P
    Nature; 2002 May; 417(6886):4-5. PubMed ID: 12015552
    [No Abstract]   [Full Text] [Related]  

  • 2. Canadian lab loses Amgen backing.
    Knight J
    Nature; 2002 May; 417(6884):4. PubMed ID: 11986629
    [No Abstract]   [Full Text] [Related]  

  • 3. Florida lures research institutes east.
    Dalton R
    Nature; 2006 Aug; 442(7104):729. PubMed ID: 16915254
    [No Abstract]   [Full Text] [Related]  

  • 4. Good neighbours.
    Niiler E
    Nature; 2003 Dec; 426(6967):690-4. PubMed ID: 14668872
    [No Abstract]   [Full Text] [Related]  

  • 5. Northern England: rising star.
    Smaglik P
    Nature; 2003 Sep; 425(6956):430-3. PubMed ID: 14508497
    [No Abstract]   [Full Text] [Related]  

  • 6. University-industry collaboration. Last of the big-time spenders?
    Lawler A
    Science; 2003 Jan; 299(5605):330-3. PubMed ID: 12531991
    [No Abstract]   [Full Text] [Related]  

  • 7. Biodefence research.
    Russo E
    Nature; 2002 Apr; 416(6882):4-5. PubMed ID: 11961508
    [No Abstract]   [Full Text] [Related]  

  • 8. Biomedical research. Australia pushes stem cell advantage.
    Dayton L
    Science; 2002 Jun; 296(5574):1779-81. PubMed ID: 12052925
    [No Abstract]   [Full Text] [Related]  

  • 9. Among the best.
    Jayaraman KS
    Nature; 2005 Jul; 436(7050):492-5. PubMed ID: 16049476
    [No Abstract]   [Full Text] [Related]  

  • 10. Berlin aims to create research powerhouse.
    Schiermeier Q
    Nature; 2012 Nov; 491(7424):317. PubMed ID: 23151558
    [No Abstract]   [Full Text] [Related]  

  • 11. Blurred vision.
    Smaglik P
    Nature; 2002 Dec; 420(6916 Suppl):A19, A21, A23. PubMed ID: 12501122
    [No Abstract]   [Full Text] [Related]  

  • 12. National Academies launch grants for interdisciplinary work.
    Check E
    Nature; 2003 Apr; 422(6934):791. PubMed ID: 12712156
    [No Abstract]   [Full Text] [Related]  

  • 13. Upending the zeitgeist.
    Nature; 2006 Jun; 441(7093):572-3. PubMed ID: 16738631
    [No Abstract]   [Full Text] [Related]  

  • 14. Falling share price stymies gift to university.
    Dalton R
    Nature; 2002 Aug; 418(6897):468. PubMed ID: 12152042
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of the "new science" of genomics.
    Coile RC
    J Healthc Manag; 2001; 46(6):365-8. PubMed ID: 11729566
    [No Abstract]   [Full Text] [Related]  

  • 16. Canada. Amgen splits with lab, but its money lingers.
    Kondro W
    Science; 2002 Jun; 296(5576):2123-4. PubMed ID: 12077379
    [No Abstract]   [Full Text] [Related]  

  • 17. Turkish biomed hub spurs hope amid political strife.
    Abbott A
    Nature; 2015 Oct; 526(7572):171-2. PubMed ID: 26450035
    [No Abstract]   [Full Text] [Related]  

  • 18. Biotechnology development a stroll in the park?
    Dove A
    Nat Biotechnol; 2000 Mar; 18(3):270-2. PubMed ID: 10700137
    [No Abstract]   [Full Text] [Related]  

  • 19. Commercialization of academia research.
    Jamali F
    J Pharm Pharm Sci; 1999; 2(3):88. PubMed ID: 10953253
    [No Abstract]   [Full Text] [Related]  

  • 20. Interdisciplinary science: Harvard under review.
    Lok C
    Nature; 2008 Aug; 454(7205):686-9. PubMed ID: 18685675
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.